REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 36 filers reported holding REPROS THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $773,000 | +62.4% | 1,171,544 | -21.2% | 0.00% | – |
| Q3 2017 | $476,000 | -32.9% | 1,486,144 | -3.6% | 0.00% | – |
| Q2 2017 | $709,000 | -62.8% | 1,540,844 | -3.0% | 0.00% | – |
| Q1 2017 | $1,906,000 | -13.7% | 1,588,044 | -5.1% | 0.00% | – |
| Q4 2016 | $2,209,000 | -36.8% | 1,673,644 | 0.0% | 0.00% | – |
| Q3 2016 | $3,498,000 | +29.8% | 1,673,644 | 0.0% | 0.00% | – |
| Q2 2016 | $2,695,000 | +21.5% | 1,673,644 | -26.8% | 0.00% | – |
| Q1 2016 | $2,218,000 | -49.7% | 2,286,602 | -37.2% | 0.00% | -100.0% |
| Q4 2015 | $4,406,000 | -83.7% | 3,641,425 | 0.0% | 0.00% | -75.0% |
| Q3 2015 | $27,056,000 | +3.9% | 3,641,425 | 0.0% | 0.00% | +33.3% |
| Q2 2015 | $26,036,000 | -3.6% | 3,641,425 | +15.8% | 0.00% | 0.0% |
| Q1 2015 | $27,017,000 | -10.6% | 3,145,146 | +3.8% | 0.00% | -25.0% |
| Q4 2014 | $30,220,000 | +24.0% | 3,031,056 | +23.2% | 0.00% | +33.3% |
| Q3 2014 | $24,365,000 | +41.6% | 2,461,083 | +147.4% | 0.00% | +50.0% |
| Q2 2014 | $17,212,000 | -5.6% | 994,928 | -3.2% | 0.00% | -33.3% |
| Q1 2014 | $18,239,000 | -0.7% | 1,028,128 | +2.4% | 0.00% | 0.0% |
| Q4 2013 | $18,366,000 | – | 1,003,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,132,367 | $11,290,000 | 4.00% |
| SENZAR ASSET MANAGEMENT, LLC | 764,406 | $7,621,000 | 2.23% |
| DESTRIER CAPITAL MANAGEMENT LLC | 329,030 | $3,280,000 | 0.88% |
| RTW INVESTMENTS, LP | 229,364 | $2,287,000 | 0.85% |
| CQS Cayman LP | 700,000 | $6,979,000 | 0.46% |
| GENERAL AMERICAN INVESTORS CO INC | 508,375 | $5,068,000 | 0.40% |
| Alden Global Capital Ltd | 154,000 | $1,535,000 | 0.37% |
| J. Goldman & Co LP | 197,500 | $1,969,000 | 0.23% |
| Baker Brothers Advisors | 2,000,000 | $19,940,000 | 0.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 100,000 | $997,000 | 0.17% |